Abstract
Thirty-five patients with carcinoma of the bladder were subjected to weekly intravesical instillation treatment with 30 mg adriamycin/50 ml solution for a period of 6 weeks following transurethral resection of the tumour. The oncolytic and thus recurrence-preventive value of treatment was determined by endoscopic controls with exploratory excisions and exfoliative cytology. All in all, a recurrence-free rate was found in 77% over a minimum observation period of one year. These results are definitely better than those of comparable instillation treatments with surface-active or immunologically active substances.
Similar content being viewed by others
References
Banks, M. D., Pontes, J. E., Izbicki, R. M., Pierce, J. M. Jr.: Topical instillation of doxorubicin hydrochloride in the treatment of recurring superficial transitional cell carcinoma of the bladder.J. Urol., 118, 757 (1977).
Edsmyr, F., Berlin, T., Boman, J., Duchek, M., Esposti, L. P., Gustafsson, H., Wijkstrom, H., Collste, L. G.: Intravesical therapy with adriamycin in patients with superficial bladder tumours.Eur. Urol., 6, 132 (1980).
Eksborg, S.: Measurements of plasma levels of adriamycin and adriamycinol after intravesical instillation of adriamycin. WHO Collaborating Centre Conference on Diagnostics and Treatment of Superficial Urinary Bladder Tumours. Karolinska Universität, Stockholm, 15. 9. 1978.
Evard, J. P., Bollag, W.: Konservative Behandlung der Harnblasenpapillomatose mit Vitamin-A-Säure.Schweiz. Med. Wochenschr., 102, 1880 (1972).
Fitzpatrick, J. M., Khan, O., Oliver, R. T. D., Riddle, P. R.: Long term follow-up in patients with superficial bladder tumours by intravesical Epodyl.Br. Assoc. Urol. Surg. Bristol (1979).
Flamm, J.: Intravesikale Instillationsbehandlung mit Adriamycin in der Nachbehandlung transurethral resezierter Harnblasenkarzinome.Urol. Int. (in press).
Flamm, J., Grof, F.: Adjuvante lokale Instillationsbehandlung mit Vitamin-A in der Nachbehandlung transurethral resezierter Harnblasentumoren.Urologe [A] (in press).
Flamm, J., Grof, F.: Adjuvante lokale Immunotherapie mit Bacillus Calmette Guérin (BCG) in der Behandlung des Urothelcarcinoms der Harnblase.Wien. Med. Wochenschr. (in press).
Flamm, J.: Zur Korrelation des Immunprofils mit der lokalen Immunozyteninfiltration bei Harnblasentumoren (in press).
Flamm, J.: Die prognostische Bedeutung des Immunstatus (DNCB-test) kontrolliert durch Verlaufsbeobachtungen beim Harnblasenkarzinom.Wien. Med. Wochenschr. (in press).
Garvell, G. J., Lewis, R. W., Meehan, W. L., Leblanc, G. A.: Intravesical Thio-Tepa in the immediate postoperative period in patients with recurrent transitional carcinoma of the bladder.J. Urol., 120, 410 (1978).
Hohenfellner, R.: Harnblasenkarzinom. Klinisches Referat.Verh. Dtsch. Ges. Urol. Springer, Berlin 1977, p. 8.
Jacobi, G. H., Kurth, K. H., Klippel, K. F., Hohenfellner, R.: On the biological behaviour of T1-transitional cell tumours of the urinary bladder and initial results of the prophylactic use of topical adriamycin under controlled randomized conditions. WHO Collaborating Centre Conference on Diagnostics and Treatment of Superficial Urinary Bladder Tumours, Karolinska Universität, Stockholm, 15. 9. 1978.
Jacobi, G. H.: Topische intravesikale Anwendung von Chemotherapeutica beim Übergangszell-Epitheltumor der Harnblase. I. Adjuvante Rezidiv-Chemoprophylaxe.Therapiewoche, 29, 5954 (1979). Verlag G. Braun, Karlsruhe.
Mauermayer, W., Tauber, R., Steuer, G., Schwarz, W.: Die transurethrale Resektion des Harnblasenkarzinoms.Verh. Dtsch. Ges. Urol. Springer, Berlin 1977, p. 12.
Morales, A., Eidinger, D., Bruce, A. W.: Intracavitary Bacillus Calmette-Guérin in the treatment of superficial bladder tumours.J. Urol., 116, 180 (1976).
Niijima, T.: Intravesical therapy with adriamycin and new trends in the diagnostics and therapy of superficial urinary bladder tumours. WHO Collaborating Centre Conference on Diagnostics and Treatment of Superficial Urinary Bladder Tumours. Karolinska Universität, Stockholm, 15. 9. 1978.
Oomaru, T.: Intravesical mitomycin-C treatment for bladder cancer.Urol. West. Jap., 35, 510 (1973).
Stöber, U.: Der Einfluß der Lymphozyteninfiltration in Tumorgewebe auf Zeitpunkt und Infiltrationstendenz von Blasenkarzinomrezidiven.Urologe [A],17, 296 (1978).
UICC, International Union Against Cancer: TNM classification of malignant tumours. 3rd edition, Geneva 1978.
WHO, World Health Organisation: International histological classification of tumours. No. 10: Histological typing of urinary bladder tumours. Geneva 1973.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Flamm, J., Grof, F. Prophylactic use of topical adriamycin after transurethral resection of transitional cell bladder tumours. International Urology and Nephrology 17, 143–147 (1985). https://doi.org/10.1007/BF02082485
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02082485